Increased expression of cytokeratins 14, 18 and 19 correlates with tumor progression in the uterine cervix

被引:0
|
作者
Nair, SA
Nair, MB
Jayaprakash, PG
Rajalekshmy, TN
Nair, MK
Pillai, MR
机构
[1] REG CANC CTR,DIV LAB MED,THIRUVANANTHAPURAM 695011,KERALA,INDIA
[2] REG CANC CTR,DEPT RADIAT ONCOL,THIRUVANANTHAPURAM,KERALA,INDIA
[3] SAT HOSP,DEPT OBSTET & GYNECOL,THIRUVANANTHAPURAM,KERALA,INDIA
[4] DIAGNOST & RES CTR,DEPT PATHOL & DOCTORS,THIRUVANANTHAPURAM,KERALA,INDIA
关键词
uterine cervix; cytokeratin; squamous intraepithelial lesion; immunoreactivity; squamous cell carcinoma;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The expression of cytokeratins (CKs) in normal cervical ephitelium, lour grade squamous intraepithelial lesions (SIL), high grade SILs and squamous cell carcinoma (SCC) were analyzed using four different monoclonal antikeratin antibodies. In normal cervical epithelium, CK 18 showed strong immunoreactivity in basal and parabasal layers. CK 19 and 14 were expressed only in the basal layer while CK 13 was found selectively in the spinal cells. As the lesions progressed from low grade SIL to high grade SIL, immunoreactivity of CK 18, 19 and 14 in the basal cell compartment increased while the expression of CK 13 decreased. In SCC, well-differentiated tumors showed decreased immunoreactivity for CK 18, 19 and 14 with CK 13 showing a strong and focal (localized) immunoreactivity. Undifferentiated carcinomas totally lacked CK 13 reactivity. Our findings therefore suggest that expression of CK 18, 19 and 14 may be directly related to tumor grade and CK 13 may be a marker of differentiation in cervical lesions.
引用
收藏
页码:100 / 107
页数:8
相关论文
共 50 条
  • [1] CYTOKERATINS AND TUMOR PROGRESSION IN THE UTERINE CERVIX
    NAIR, SA
    LAKSHMI, S
    KANNAN, S
    NAIR, MK
    PILLAI, MR
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1995, 14 (02) : 131 - 138
  • [2] Expression of GSDML Associates with Tumor Progression in Uterine Cervix Cancer
    Sun, Qiao
    Yang, Juntao
    Xing, Guichun
    Sun, Qihong
    Zhang, Lingqiang
    He, Fuchu
    TRANSLATIONAL ONCOLOGY, 2008, 1 (02): : 73 - U30
  • [3] EXPRESSION OF CYTOKERATINS IN EARLY NEOPLASTIC EPITHELIAL LESIONS OF THE UTERINE CERVIX
    PUTS, JJG
    MOESKER, O
    KENEMANS, P
    VOOIJS, GP
    RAMAEKERS, FCS
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1985, 4 (04) : 300 - 313
  • [4] Involucrin and tumor progression in the uterine cervix
    Nair, SA
    Nair, MB
    Jayaprakash, PG
    Rajalekshmy, TN
    Nair, MK
    Pillai, MR
    PATHOBIOLOGY, 1996, 64 (06) : 333 - 338
  • [5] Expression of CHOP in Souamous Tumor of the Uterine Cervix
    Chu, Hyun Hee
    Bae, Jun Sang
    Kim, Kyoung Min
    Park, Ho Sung
    Cho, Dong Hyu
    Jang, Kyu Yun
    Moon, Woo Sung
    Kang, Myoung Jae
    Lee, Dong Geun
    Chung, Myoung Ja
    KOREAN JOURNAL OF PATHOLOGY, 2012, 46 (05) : 463 - 469
  • [6] Matrix metalloproteinase 9 in the uterine cervix during tumor progression
    Talvensaari-Mattila, A
    Turpeenniemi-Hujanen, T
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2006, 92 (01) : 83 - 84
  • [7] Neuroendocrine tumor of the uterine cervix: a clinicopathologic study of 14 cases
    Peng Peng
    Wu Ming
    Yang Jiaxin
    Shen Keng
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2012, 286 (05) : 1247 - 1253
  • [8] Neuroendocrine tumor of the uterine cervix: a clinicopathologic study of 14 cases
    Peng Peng
    Wu Ming
    Yang Jiaxin
    Shen Keng
    Archives of Gynecology and Obstetrics, 2012, 286 : 1247 - 1253
  • [9] RAS ONCOGENE EXPRESSION AND PROGRESSION IN INTRAEPITHELIAL NEOPLASIA OF THE UTERINE CERVIX
    SAGAE, S
    KUDO, R
    KUZUMAKI, N
    HISADA, T
    MUGIKURA, Y
    NIHEI, T
    TAKEDA, T
    HASHIMOTO, M
    CANCER, 1990, 66 (02) : 295 - 301
  • [10] Loss of ARID1A Expression Correlates with Stages of Tumor Progression in Uterine Endometrioid Carcinoma
    Mao, T-L
    Ardighieri, L.
    Li, R.
    Lin, M-C
    Ayhan, A.
    Kurman, R. J.
    Shih, I-M
    MODERN PATHOLOGY, 2012, 25 : 286A - 286A